Journal of Hepatology
Publisher: Elsevier · ISSN 0168-8278 · 80 articles
- Difficult diagnoses: Quando è notte, è notte per tutti
- Triple parallel TIPS for porto-sinusoidal vascular disorder with refractory hemorrhage: Portal hypertension, but not as we know it
- Agree to disagree: Increasing the impact of recommendations formulated through Delphi methodology
- Reply to: “Agree to disagree; increasing the impact of recommendations formulated through Delphi methodology”
- Single-nucleus and spatial transcriptomic analyses reveal intra-tissue heterogeneity of PNPLA3
- Reply to: “Single-nucleus and spatial transcriptomic analyses reveal intra-tissue heterogeneity of PNPLA3”
- Role of HBV genotype, monitoring, and events after cessation of nucleos(t)ide analogue therapy
- Reply to: “Role of HBV genotype, monitoring, and events after cessation of nucleos(t)ide analogue therapy”
- IFRD1: A promising target in human liver regeneration
- Reply to: “IFRD1: A promising target in human liver regeneration”
- Circulating FGF21 levels reflect liver disease risk and metabolic stress in the UK Biobank
- Rejection and perioperative management in liver transplantation following immune checkpoint inhibitor–based downstaging for hepatocellular carcinoma
- Reply to: “Rejection and perioperative management in liver transplantation following immune checkpoint inhibitor–based downstaging for hepatocellular carcinoma”: Revisiting rejection after immune checkpoint inhibitor exposure prior to liver transplantation for hepatocellular carcinoma
- Refining ACLF diagnosis: Beyond the scorecard
- Reply to: “Optimizing clinical adoption of large language models in hepatology: Toward terminological precision, multilingual adaptability, and interpretive literacy”
- Liver biopsy confirms precise and efficient correction of SERPINA1 after in vivo Base Editing in a Patient with Alpha-1 Antitrypsin Deficiency
- Seladelpar for alkaline phosphatase normalization in primary biliary cholangitis: The IDEAL phase III randomized controlled trial
- Senescence induces clonal failure of hepatocyte plasticity and reshapes regenerative lineages
- T cells and the bile duct: CD226-NECTIN2 as a druggable axis in immune-mediated cholangiopathy
- Translocation of the environmental bacterium Aquitalea magnusonii promotes systemic inflammation and liver fibrosis in chronic liver disease